Anna Pellat, MD, MSc
I have been working on transparency and levels of evidence of research in pancreatic adenocarcinoma. Following my initial work, I am now focusing on the role of observational studies and evaluating how it challenges the current framework of evidence in medical research.
In parallel, I am also associated with the ESMO real-world and digital health working group where I work on several projects regarding real-world evidence in oncology. I am co-leading one of the projects.
Finally, as a medical doctor, I also work part-time in the digestive oncology department of the Cochin hospital in Paris, where I will then pursue my academic career at the end of my PhD.
Framework of evidence in medical research
Observational and real-world evidence in clinical oncology research
Levels of Evidence Supporting United States Guidelines in Pancreatic Adenocarcinoma Treatment. Pellat A, Boutron I, Coriat R, Ravaud P.Cancers (Basel). 2022 Aug 22;14(16):4062. [Paper]
Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years. Pellat A, Boutron I, Ravaud P.Oncologist. 2022 Nov 3;27(11):e849-e855. [Paper]